Search
Omnicell Inc
OMCLAdd to Watchlist
39.050USD
+0.550+1.43%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
1.76BMarket Cap
87.56P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Omnicell Inc is 8.00, ranking 66 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 47.00, with a high of 63.00 and a low of 36.00.
Analyst Rating
Based on
8
analysts
Buy
Current Rating
61.286
Target Price
+59.18%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
94
Total
3
Median
7
Average
Company name
Ratings
Analysts
Omnicell Inc
OMCL
8
Boston Scientific Corp
BSX
37
Intuitive Surgical Inc
ISRG
35
Edwards Lifesciences Corp
EW
34
Thermo Fisher Scientific Inc
TMO
30
Veeva Systems Inc
VEEV
29
1
2
3
...
19
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Omnicell Inc's expected revenue for the next quarter?
Omnicell Inc's expected revenue is 310.25M.
What is Omnicell Inc's price target?
Analysts forecast that Omnicell Inc's price target is USD 47.00, with the highest forecast at USD 63.00 and the lowest forecast at USD 36.00.
How have Omnicell IncOMCL's recent earnings per share performed?
The market expectation was USD 0.25, while Omnicell IncOMCL's earnings per share (EPS) for the previous quarter was USD -0.05. EPS for the next quarter is expected at USD 0.47.
What is the analyst rating for Omnicell Inc?
Based on the ratings of Omnicell Inc's stock from 8 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
